In July, Pfizer announced it is advancing development of a once-daily formulation of the oral GLP-1 receptor agonist danuglipron
L-carnitine in the treatment of mild or moderate hepatic encephalopathy
In a study published in the New England Journal of Medicine , participants using Semaglutide lost up to 15% of their body weight over 68 weeks, compared to 2.4% in the placebo group
showed that, in a microenvironment deprived of glutamine, due to glutamine addiction in clear cell renal cell carcinoma (ccRCC), tumor-associated macrophages (TAMs) promote an immunosuppressive microenvironment [154]
Many patients wonder whether they can inject into the thigh rather than the abdomen, especially for convenience or comfort reasons
Losing weight quickly can put stress on the body, leading to muscle aches and joint discomfort